Скачать или смотреть NanoViricides, Inc. (NYSE American: NNVC) Webcast | SNN Network

NanoViricides, Inc. (NYSE American: NNVC) Full webcast at the Planet MicroCap Showcase Virtual Investor Conference 2020.

For more information about NanoViricides, Inc., please visit: http://nanoviricides.com/

The interview may contain forward looking statements about NanoViricides, Inc. See NanoViricides, Inc.'s periodic filings with the Securities and Exchange Commission for more complete information.

About NanoViricides, Inc.

NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for antiviral therapy. Our lead drug candidate is NV-HHV-101 with its first indication as dermal topical cream for the treatment of shingles rash. The Company is also developing drugs against SARS-CoV-2 virus for the treatment of COVID-19 disease, and a number of other viral diseases including oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. The Company's novel nanoviricide® class of drug candidates are designed to specifically attack virus particles by mimicking the same receptor sites that viruses use to bind to cells, enveloping and then dismantling them, thereby blocking the reinfection cycle. This goes beyond what antibodies and immunotherapeutics can do. Our unique biomimetic approach enables creation of drugs that a virus would be highly unlikely to escape due to mutations. The Company's technology is based on broad, exclusive, sub-licensable, field licenses from TheraCour Pharma, Inc. While the Company does not currently have a license to the coronavirus field, TheraCour has not denied any licenses to the Company. The Company typically begins the licensing process only after demonstrating effectiveness of some candidates in optimization stage.

Subscribe NOW to SNN Network: http://bit.ly/1Q5Yfym

New videos are added almost every day to the SNN Network channel sharing fascinating stories and companies from the MicroCap stock market.

Get more SNN Network:
Website: http://stocknewsnow.com/
Follow Stock News Now:   / stocknewsnow  
Like Stock News Now:   / snninc  
Follow Stock News Now on LinkedIn:   / stoc.  .
Follow Stock News Now on StockTwits: http://stocktwits.com/StockNewsNow

SNN.Network is the Official YouTube Channel for the Small-, Micro- and Nano-cap markets by providing news, insights, education tools and expert commentary. Subscribe now to be notified when new CEO video interviews, WALL STREET VIEWS with investing experts and new episodes of the Planet MicroCap Podcast are LIVE!

DISCLAIMER AND FORWARD LOOKING STATEMENT NOTICE

All information presented in all forms at the Planet MicroCap Showcase or in press releases, videos, emails, or otherwise posted on our website, stocknewsnow.com or YouTube channel (the “Outlets”) is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Stock News Now, SNN Inc., and the Planet MicroCap Showcase, and their representatives (“our,” “us,” and “we”) are not licensed brokers, broker/dealers, market makers, investment bankers, investment advisers, analysts, or underwriters. Any presentation on or at any of our Outlets is for informational purposes only and we do not recommend any company that may appear or present in any capacity on or at any of our Outlets. A company’s actual results could differ materially from those described in any forward-looking statements or presentation on or at any of our Outlets. Information within presentations or communications may contain “forward looking” statements. Forward-looking statements are based upon expectations, estimates, and projections at the time the statements are made and involve risks and uncertainties that could cause actual events to differ materially from those anticipated. Forward-looking statements may be identified through the use of words such as expects, anticipates, estimates, believes, or by statements indicating certain actions may, could, should, or might occur. We receive cash compensation from presenters, sponsors, and participants who utilize our Outlets. We do not receive compensation for, and do not engage in, providing advice, making recommendations, issuing reports, or furnishing analyses on any of the companies, securities, strategies, or information presented. We may buy and sell securities in any company mentioned and may profit in the event those securities rise in value. There are risks involved in any investment. We are not analysts and investing in securities is for individuals with high risk tolerance and not for the general public. We recommend you consult with a professional investment adviser, broker, or legal counsel before purchasing or selling any securities referenced on or at any of our Platforms.